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ABSTRACT
The methylation of CpG dinucleotides has become
a topic of great interest in cancer research, and the
methylation of promoter regions of several tumor
suppressor genes has been identified as a marker
of tumorigenesis. Evaluation of DNA methylation
markers in tumor tissue requires hundreds of sam-
ples, which must be analyzed quantitatively due to
the heterogeneous composition of biological mater-
ial. Therefore novel, fast and inexpensive methods
for high throughput analysis are needed. Here we
introduce a new assay based on peptide nucleic
acid (PNA)-library hybridization and subsequent
MALDI-TOF analysis. This method is multiplexable,
allows the use of standard 384 well automated pipet-
ting,andismorespecificandflexiblethanestablished
methods, such as microarrays and MS-SNuPE. The
approach was used to evaluate three candidate colon
cancer methylation markers previously identified in
amicroarraystudy.ThemethylationofthegenesAde-
nomatous polyposis coli (APC), glycogen synthase
kinase-b-3 (GSK3b) and eyes absent 4 (EYA4) was
analyzed in 12 colon cancer and 12 normal tissues.
APC and EYA4 were confirmed as being differentially
methylated in colon cancer patients whereas GSK3b
did not show differential methylation.
INTRODUCTION
The methylation of CpG dinucleotides is an epigenetic modi-
ﬁcation that has frequently been associated with control of
gene expression (1). In particular, X-chromosomal silencing,
inactivation of retrotransposon activity, imprinting, transcrip-
tional regulation in embryogenesis and cell differentiation
are inﬂuenced by DNA methylation (2–6). Aberrant DNA
methylation patterns have been associated with a variety of
genetic diseases and cancer (7). As such, DNA methylation
markers hold great promise as research and diagnostic
tools (8).
Due to the heterogenous composition of biological material
from tissue samples, thorough investigations of methylation
patterns necessitate the analysis of samples in a quantitative
manner, in particular for applications, such as the analysis of
allele-speciﬁc methylation (imprinting). In that respect there is
a signiﬁcant need for fast and cheap methods for quantitative
DNA methylation analysis. Genome-wide discovery methods
lead to a great number of candidate markers, which have to be
evaluated on hundreds of samples (9–11). A ﬁnal diagnostic
application would also require an assay capable of handling
many specimens.
Most techniques used to analyze methylation patterns
depend on bisulﬁte treatment of the DNA. The bisulﬁte reac-
tion converts all non-methylated cytosines to uracils, whereas
methylated cytosines are not changed under the reaction con-
ditions. The methylation level can then be determined by
direct sequencing of subclones or PCR products (12,13),
matrix-assisted laser desorption/ ionization (MALDI) analysis
of RNA transcripts from bisulﬁte treated DNA (14), ﬂuores-
cence real-time PCR (MethyLight and QAMA) (15,16),
microarray based systems (11), primer extension or pyro-
sequencing (17) and several others. Most of these techniques
suffer from high analysis costs for kits and other consumables,
in particular techniques applying ﬂuorescence dyes (sequen-
cing, real-time PCR and microarrays). Other methods are not
capable of multiplex analysis (pyrosequencing and sequen-
cing). In contrast MALDI is an excellent tool to analyze
DNA methylation, due to its fast and accurate analysis
power, its multichannel analysis capability and its ability to
run quantitative analysis (18). The combination of MALDI
detection with peptide nucleic acid (PNA) probe hybridization
enables the complex analysis of DNA methylation (19).
Compared to other MALDI based methods, such as the
GOOD assay, no CpG-free extension primer sequences are
required. Therefore, the method can also be used to study
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doi:10.1093/nar/gkl218DNA methylation in CpG islands. CpG islands are often over-
lappingwith promoters particularly intumor suppressorgenes.
Their methylation status has been reported to inversely cor-
relate with expression levels (20). The analysis of CpG island
methylation status is therefore of great interest and PNA probe
hybridization represents an excellent analysis tool. In addition,
by design of suitable PNA probes the method allows the sim-
ultaneous detection of several CPGs (within a CPG island).
Therefore patterns of CPG methylation can be analyzed in a
single reaction.
PNAs are a class of DNA analogs in which the entire sugar-
phosphate backbone is replaced by a pseudopeptide. Owing to
its neutral character and the consequent lack of electrostatic
repulsion, PNA exhibits very stable heteroduplex formation
with complementary nucleic acid that is essentially ionic
strength independent, enables hybridization under minimum
salt conditions, and is more speciﬁc than DNA based hybrid-
izationmethods.Thisfeature,aswellasitssuperiorionstability
and easy ionization, compared to DNA, renders PNA very
attractive for hybridization-based MALDI time-of-ﬂight
mass spectrometry (MALDI-TOF-MS) (21–23). Analytical
sensitivity was further improved by introducing a ‘charge
tag’ into the PNA molecule (24). In our work, a method has
been established which enables the 384 well plate based ana-
lysisofimmobilizedampliﬁcatesfrombisulﬁtetreatedDNAby
PNA probes (Figure 1). Biotinylated PCR-ampliﬁcates were
prepared from bisulﬁte treated DNA using 50-biotinylated pri-
mers and immobilized in streptavidin coated microtiter plates
withoutpriorpuriﬁcation.Subsequently,aPNA-libraryhybrid-
ization was performed. After removing unspeciﬁcally bound
probes,PNAswereanalyzedwithMALDIandthemethylation
level was estimated by dividing the signal intensity of a probe
speciﬁctothemethylatedallele bythesum ofsignalintensities
of both probes (speciﬁc to the methylated and speciﬁc to the
unmethylated allele).
This enables the relative quantiﬁcation for classiﬁcation
based on the methylation levels of samples. Altogether, twelve
PNA hybridization assays were evaluated and multiplex ana-
lysis was demonstrated. Six assays were further characterized
byanalyzing mixtures of artiﬁcially methylated and unmethyl-
ated DNA. Design criteria were elucidated which will lead to
an improved probe design for expanded DNA methylation
research.
To demonstrate the viability of our method on patient sam-
ples we focused on colorectal cancer, the second most com-
mon cause of malignant death in industrialized countries.
More accurate detection markers are needed to improve the
effectiveness and efﬁciency of both screening and monitoring
of colorectal neoplasia. DNA methylation in colorectal cancer
hasbeen well-studiedinan effort toﬁndnew potential markers
for early detection (25–27). We performed our analysis on a
series of patient samples available from this neoplastic dis-
order. Two candidate DNA methylation cancer markers
recently identiﬁed in our genome-wide discovery and microar-
ray analysis (C. Lofton-Day, A. Sledziewski and K. Berlin,
unpublished data) and one marker taken from literature were
selected to evaluate the new PNA hybridization approach (36):
Glycogen synthase kinase-b-3 (GSK3b), eyes absent 4
(EYA4) and Adenomatous polyposis coli (APC).
To evaluate the three candidate markers, 24 samples (12
cancer and 12 normal) were assayed and statistical analysis
was performed. Subsequently, data were validated by
pyrosequencing.
MATERIALS AND METHODS
PNA synthesis and modification
PNA design and synthesis has been performed according
to the recommendations of Applied Biosystems
Figure 1. Methylation analysis by PNA probe hybridization and MALDI-TOF analysis. (A) DNA extracted from tissue sample. (B) Conversion of unmethylated
cytosine into uracil by bisulfite treatment. (C) PCR amplifing the upper strand with a 50-biotinylated primer. (D) Amplicon immobilization on streptavidin coated
microtiterplates;Denaturationusing200mMNaOH.(E)PNAprobehybridization;Removalofexcessprobes(red)bystringentwashing.(F)Releaseofspecifically
bound probes (green and blue) at elevated temperature (60 C); eluate transfer onto MALDI-TOF sample holder; MALDI analysis and matching of molecular mass
to sequence database.
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in a 2 mmol-scale using a PerSeptive Biosystems Expedite
8909 synthesizer. PNAs were subsequently modiﬁed with
oneofthe following trimethylammonium-alkyryl-NHS-ester:
5-Trimethyl ammonium- pentyryl- N-hydroxy- succinimidyl
ester (CT 156), 4-Trimethyl ammonium- butyryl- N-hydroxy-
succinimidyl ester (CT 142) and 3-Trimethyl ammonium-
propyl- N-hydroxy- succinimidyl ester (CT 128). The
reactions were performed according to methods described
for oligonucleotide modiﬁcation by Sauer et al. (28,29).
Synthesized PNA probes and primers are listed in Table 1.
DNA preparation
Fresh frozen samples were obtained from Integrated Labora-
tory Services (ILS, Chestertown, USA). A total of 24 patient
samples were analyzed comprising 5 normals, 5 adenocarci-
nomas and 7 matched pairs (adenocarcinoma and normal
adjacent tissue).
DNA was extracted using the QIAamp DNA puriﬁcation kit
(Qiagen,Hilden,Germany). Unmethylated DNA was prepared
by MDA (multiple displacement ampliﬁcation), a genome-
wide ampliﬁcation method described by Dean et al. (30).
Methylated DNA was prepared by treating unmethylated
MDA-DNA with SssI methyltransferase (New England
Biolabs, Frankfurt, Germany) in the presence of S-adenosyl-
methionine according to the manufacturer’s instructions.
Bisulﬁte treatment was performed as described previously (31).
PCR amplification and immobilization
Oligonucleotides listed in Table 1 were used for PCR
ampliﬁcation. Primers were designed for the following
loci: APC: AC109473.2 (61083–60963); EYA4:
AL121959.15, HSDJ78N10 (80737–80797); GSK3b:
AC092910.9 (147566–147626); hMLH1: AC011816
(143079–143139); MDR1: AC002457.2 (36792–36839).
PCR was performed in a total volume of 65 ml containing
10 ng template DNA, 2.6 U Hotstart Taq polymerase (Qiagen,
Hilden, Germany), 32.5 pmol of each forward and reverse
primer, 1· PCR buffer (Qiagen, Hilden, Germany) and
0.2 mM of each dNTP (MBI Fermentas, St. Leon-Rot,
Germany). Cycling was done using a Mastercycler
(Eppendorf, Hamburg, Germany) under the following condi-
tions: 15 min at 95 C and 40 cycles at 95 C for 1 min, 55 C
for 45 s and 72 C for 1:30 min with the following exceptions:
for all GSK3b assays 53 C annealing temperature was used
and primer 1 was used in a concentration of 1 mM. Assay
hMLH1-1 and -2 were performed with annealing at 54 C,
hMLH1-3 at 60 C and MDR1-1 at 51 C. For assay
EYA4-2 1 mM of primer 1 was used. An aliquot of 5 ml
of the PCR mix was loaded on a 2.5% agarose gel to check
PCR performance. An aliquot of 60 ml was immobilized and
denatured in a High Capacity Streptavidin (Sigma–Aldrich,
Munich, Germany) 384 well plate according to the suppliers
instructions. Wells were equilibrated for 10 min in the
hybridization buffer containing 0.7 M ammonium chloride,
70 mM ammonium citrate and 3.6% (w/v) ammonium-
laurylsarcosinate (pH 7). The buffer was replaced with
fresh hybridization buffer containing 100 nM of each PNA
probe. The plate was incubated while shaking (1000 U/ min)
using a Thermomixer 5355 Comfort (Eppendorf, Hamburg,
Germany) for 1 h at 34 C. The EYA4-2 assay was incubated
at 20 C. The plate was washed once with hybridization
buffer heated to the hybridization temperature and twice
Table 1. List of oligonucleotides and probes
Assayname Primer 1 Primer 2 M probe
a U probe
b
APC-1 50Biotin-GGAGAGAGAAGT-
AGTTGTGTAATT
ACTACACCAATACAACCACA-
TATC
CT128-OO
c-ACTCCGCAATA CT156-OO
c-ACTCCACAATA
APC-2 50Biotin-GGAGAGAGAAGT-
AGTTGTGTAATT
ACTACACCAATACAACCACA-
TATC
CT128-OO
c-AATCCGCATCC CT156-OO
c-AATCCACATCC
APC-3 50Biotin-GGAGAGAGAAGT-
AGTTGTGTAATT
ACTACACCAATACAACCACA-
TATC
CT156-OO
c-ATCGACGAACT CT156-O
c-ATCAACAAACT
EYA4-1 50Biotin-TAGGTTTTTGGAA-
GAGGTGA
CCCAAAAATCAAACAACAAC CT128-OO
c-ATTTCGTATCT CT142-O
c-ATTTCATATCT
EYA4-2 50Biotin-TTTTAGTAATGTG-
TTTAGAGAAGTTTTG
CCCAAAAATCAAACAACAAC CT128-OO
c-ACGACGT CT128-O
c-ACAACAT
GSKB-1 50Biotin-AGTGATAAAGGA-
AGGAAGGAA
CAACCCAAAACCCTATCAAC CT128-OO
c-TCAACGACTAC CT128-O
c-TCAACAACTAC
GSKB-2 50Biotin-AGTGATAAAGGA-
AGGAAGGAA
CAACCCAAAACCCTATCAAC CT156-OO
c-CGAAACCGACT CT156-O
c-CAAACCAACT
GSKB-3 50Biotin-AGTGATAAAGGA-
AGGAAGGAA
CAACCCAAAACCCTATCAAC CT128-OO
c-TCCTCGCTTCC CT128-O
c-TCCTCACTTCC
hMLH1-1 50Biotin-TTTTTAGGAGTGA-
AGGAGGTT
TAAAACCCTATACCTAATCT CT156-OO
c-CGTCTACGTCA CT142-OO
c-CATCTACATCA
hMLH1-2 50Biotin-TTTTTAGGAGTGA-
AGGAGGTT
TAAAACCCTATACCTAATCT CT142-OO
c-CGCCACTACGA CT128-O
c-CACCACTACAA
hMLH1-3 50Biotin-TGAAGGGTGGGGT-
TGGAT
TTCAACCAATCACCTCAATA-
CC
CT156-O
c-CTCACGTTCTT CT128-OO
c-CTCACATTCTT
MDR1-1 50Biotin-GAAGATTTATGTG-
AATTTTGAAAG
AAACATTTCAACTTATATAA-
ACAC
CT156-OO
c-AACACGTCTTT CT156-OO
c-AACACATCTTT
aM probe: PNA probe reverse complementary to methylated sequence.
bU probe: PNA probe reverse complementary to unmethylated sequence.
cChemical modifications: O ¼ O-linker ({2-[2-(Fmoc-amino)ethoxy]acetic acid; CT156 ¼ N-Propyl-5-Trimethylammoniumpentylamid; CT142 ¼ N-Propyl-4-
Trimethylammonium-butyrylamid and CT128 ¼ N-Propyl-3-Trimethylammonium-propylamid.
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and heated to 60 C for 10 min. Twice 0.5 ml of eluate was
transfered to a ScoutTM384 stainless steel target plate
precoated with 0.5 ml of 0.2% (w/v) a-cyano-4-methoxy-
cinnamic acid, 1.8% (w/v) a-cyano-4-hydroxy-cinnamic
acid methyl ester in acetone. After drying, 0.5 ml 0.01%
ammonium hydroxide was added.
MALDI-TOF analysis
Automated analyses were carried out on a Biﬂex III mass
spectrometer using the AutoXecute software (Bruker
Daltonics, Bremen, Germany). Mass spectra were recorded
in the positive ion linear time-of-ﬂight mode. Acceleration
potentials of IS/1 19 kV and 17.5 kV IS/2 were used. Detector
potential was set on 1.7 kV. Ion extraction was delayed by
200 ns. The detector was gated to prevent saturation by
molecules smaller than 1200 Da. Usually 16 · 25 shots
were accumulated per sample spot, smoothed using a Golay-
Savitzky ﬁlter and baseline-corrected. Spectra with a signal to
noise range > 12 and a resolution > 310 were collected. All
others were discarded. The Genotool SNP manager was used
to automatically analyze the spectra and yield the relative
intensities of the peaks. Each analysis was performed in
duplicate and each eluate was measured twice resulting in
four data points per analysis.
Data analysis
Methylation levels were calculated by dividing the signal
intensity of the CG-peak by the sum of the signal intensities
of both corresponding PNA probes [Methylation Level ¼
CG/(CG + CA)]. Distributions of measured samples were
visualized using a box-whisker-plot. A total of 75% of the
data were represented by the box and 95% of the data by
the whiskers. Data outside the 95th percentile were marked
as outliers.Classiﬁcations ofdistributions were analyzed using
a non-parametric (Wilcoxon) test.
Pyrosequencing
Pyrosequencing was performed as described by Tost et al. (17)
using a PSQ  station and a PSQ 96MA system (Pyro-
sequencing AB). For the ampliﬁcation, the following primers
were used: Biotin-AGTGAtAAAGGAAGGAAGGAA and
AAACAACTCCCTTCAAACC (GSK3b), Biotin-GGTTAG-
GGTTAGGTAGGTTGT and ACTACACCAATACAACCA-
CATATC (APC), and for EYA4 Biotin-TAGGTTTTTG-
GAAGAGGTGA and CCCAAAAATCAAACAACAAC
(EYA4). PCR was performed in a total volume of 25 ml
containing 10 ng template DNA, 1 U Hotstar Taq polymerase
(Qiagen, Hilden, Germany), 12.5 pmol of forward and reverse
primers, 1· PCR buffer (Qiagen, Hilden, Germany), 0.2 mM
of each dNTP (MBI Fermentas, St. Leon-Rot, Germany).
Cycling was done using a Mastercycler (Eppendorf, Hamburg,
Germany) with the following conditions: 15 min at 95 C and
40 cycles at 95 C for 1 min, 55 C for 45 s and 72 C for 1:30
min. The following biotinylated oligonucleotides were used as
extension primers for the pyrosequencing reaction: APC
CCACACCCAACCAA; EYA4 ACTTACTTCCAAAC and
GSK3b CCCAAAACCCTATCAA.
RESULTS AND DISCUSSION
MALDI-TOF represents a sensitive and easily automatable
method for the detection and unambigious identiﬁcation of
biomolecules and fragments thereof. Recently, quantitative
analysis using MALDI-TOF has been described by standard-
izing the signal to an internal control (14,18). To study the
suitability of the technique for quantitative methylation
analysis, bisulﬁte speciﬁc primers with a 50-biotin label on
the forward primer were used to amplify the promoter region
of the multidrug resistance protein 1 (MDR1). Ampliﬁcation
was performed with mixtures of bisulﬁte treated methylated
and unmethylated template DNA. Ampliﬁcates were immo-
bilized in different wells of a 384 well streptavidin coated
microtiter plate and subjected to a NaOH washing step to
remove the unlabeled reverse strand (Figure 1D). A set of
two methylation-speciﬁc PNA probes was hybridized
(Figure 1E). After removal of the supernatant and stringent
washing the wells were incubated with elution buffer at
elevated temperature. Microliter volumes of the elution buffer
were then directly transferred to a MALDI steel target, mixed
with organic matrix and analyzed in the positive ion mode
using a Bruker Biﬂex III instrument (Figure 1F).
MALDI spectra for DNA mixtures representing different
methylation states of a speciﬁc CpG position and PNA probe
sequences are shown in Figure 2. Different numbers of
50 linker residues were incorporated during PNA probe syn-
thesis to guarantee optimum peak separation of the two probe
signals. A quarternary ammonium moiety was added to the
linker to facilitate ionization (24). Comparison of the spectra
obtained for 100% methylated and 0% methylated DNA
demonstrates that both PNA probes hybridize with high,
although not complete speciﬁcity to the respective immo-
bilized templates (Figure 2A). In addition, methylation levels
were calculated and plotted against the methylation state
represented by the hybridization template. The resulting
response curve is linear with a correlation coefﬁcient of
0.98. Only minor deviations were detectable between two
independent experiments indicating the feasibility of
MALDI-TOF analysis for quantitative methylation analysis
via PNA probe hybridization. Due to a low level of unspeciﬁc
hybridization a slope <1 is observed.
To further characterize the scope of the method and to
pinpoint important design parameters ﬁve additional assays
were designed and characterized as described before. For the
analysis of EYA4 (Figure 3A) and APC (3B) PNA probes
covering two adjacent CpG postions were synthesized. In
addition, probes addressing single CpG positions were used
in hMLH1 (3C) and in GSK3b (3D).
When comparing the different response curves, one can
conclude that the slope is high on average when a PNA
probe pair addresses two CpG positions simultaneously but
is lower when a single CpG is analyzed (3C). Since in this
experiment both positions are either methylated or unmethyl-
ated this observation is easily explained by the increased
hybridization temperature difference between match and mis-
match. Evaluation of a total of 12 PNA hybridization assays
led to the observation that the assay performed better with
short ampliﬁcates and probes with a low C-content
(Table 2). This was indicated by a higher difference in the
measured methylation level between artiﬁcially methylated
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increased measurement range of the method. The negative
inﬂuence of longer ampliﬁcates (>100 bp) can be explained
by the higher tendency of long fragments to form secondary
structures (32,33). The ﬁnding that neighbored C:G pairing
stabilizes mismatch pairing has been already described by
Ratilainen et al. (34). In summary the number of analyzed
CpGs per PNA probe, the length of the PCR product and
the C-content all inﬂuence assay performance.
Multiplex analysis was performed to analyze several CpG
positions simultaneously, and was compared to the singleplex
analysis (Figure 4). Mixtures of different methylation levels
were analyzed and a CG / (CG + CA) ratio was calculated. As
shown in Figure 4 the results obtained by singleplex and mul-
tiplex analysis are highly correlated. In Figure 5 representative
spectra from the corresponding multiplex analysis are shown.
The methylation level of the analyzed sample can be clearly
identiﬁed when comparing the peak patterns. Lower masses
1 U to 3 U identiﬁed PNA probes with reverse complement-
arity to unmethylated DNA. High mass probes 1 M to 3 M
were speciﬁc for the methylated allele.
To demonstrate that the method is not limited to the analysis
of artiﬁcial template material, the methylation state of a set of
colon tumor and normal adjacent colon tissue samples was
analyzed using three assays (Figure 6). The promoter regions
of two of these genes were previous reported to be differen-
tially methylated in colon cancer by a genome-wide discovery
method (methylation-speciﬁc arbitrarily primed PCR) (9) and
microarray analysis (F. Model, C. Lofton-Day and K. Berlin,
unpublished data). The gene APC has been described (26).
DNA was extracted, bisulﬁte treated (31) and assayed as
described previously (Figure 1). Valid data were obtained
for all samples and are presented in Figure 6.
APC promoter
The productof the APC tumorsuppressor gene was reported to
regulate the Wnt signaling pathway through beta-catenin
(35,36). APC promoter methylation has been frequently
described (37–40). [Using methylation specifc PCR (MSP)]
Esteller etal.(26) reportedthat 18%ofpatientswith colorectal
colon carcinoma without inherited APC mutations to exhibit
hypermethylation of the APC promoter in the tumor tissue.
The hybridization assay was designed to ﬁt the promoter
region analyzed by these authors. In most samples, negligible
methylation was measured which cannot be separated from the
background control (methylation level  0.1). However, 3 out
of 12 tumor samples exhibited signiﬁcantly elevated methyl-
ation levels, similar to the proportion reported by Esteller et al.
(26). Methylation indices from cancer samples differed signi-
ﬁcantly from normals (non-parametric Wilcoxon test P-value
0.04783).Using pyrosequencing asanindependentmethod the
mean methylation level of the two CpG positions of interest in
these tumor samples was veriﬁed to be indeed signiﬁcantly
higher with 0.08 (0.25), 0.54 (0.38) and 0.79 (0.55), respect-
ively, than for all other samples, for which values close to
0( <0.1) were obtained (PNA hybridization data given in
parenthesis).
GSK3b
GSK3b has been identiﬁed by methylation-speciﬁc AP-PCR
as a candidate methylation marker in colorectal cancer
(C. Haeﬂiger, R. Lesche, S. Maier and K. Berlin, unpublished
data). Like APC, Glycogen-Synthase-Kinase-3 (GSK3b) has
been implicated with the regulation of the b-Catenin/Tcf sig-
naltransduction and is regulated by the Wnt-pathway (41).
When analyzing the GSK3b promoter region similar methyla-
tion indices were found for all analyzed samples, i.e. no dif-
ferential methylation in colon cancer could be demonstrated.
As indicated by Figure 3D a methylation level of approxim-
ately 0.2 was obtained on unmethylated DNA for this assay.
Accordingly, the elevated methylation indices for all samples
may be attributed to non-speciﬁc binding of the CG speciﬁc
probe regardless of methylation state. The lack of classiﬁca-
tion by PNA hybridization was again conﬁrmed by
pyrosequencing analysis of the same samples.
EYA4
EYA4 was ﬁrst identiﬁed by microarray analysis as being
differentially methylated in tumors (42). EYA4 is one of
four members of the EYA gene family that is homologous
tothe eyes absentgene inDrosophilamelanogaster(43).Itisa
non-thiol protein tyrosine phosphatase with an intrinsic ability
to regulate transcriptional effects in mammalian organo-
genesis (44). Mutations in EYA4 are correlated with defects
in ocular development in Drosophila ﬂies and dilated
Figure 2. Quantitative analysis of single CpG methylation within the MDR1
gene. (A) MALDI spectra of calibration experiment: PCR on mixtures of
bisulfite treated DNA representing different methylation levels; Hybridization
using MDR1-U1 AACACATCTTT (3238.98 Da) and MDR1-M1 AA-
CACGTCTTT (3399.64 Da). (B) Response curve: ratios of the signal intensity
of the probe reverse complementary to the methylated DNA sequence to the
sum of both probes plotted against the methylation levels present in the mix-
tures. Squares represent median of two independent experiments with two
replicates each; R
2 ¼ 0.98.
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that aberrant expression in the steady state level of EYA4
triggers distinct apoptotic mechanisms, implicating these
genes as possible regulators of programmed cell death (45).
EYA4hypermethylation has been shown in esophageal adeno-
carcinomas and colorectal cancer (46). EYA4 ampliﬁcates
have been selected according to Haeﬂiger et al. (44). PNA
hybridization demonstrates methylation in all analyzed
samples, but signiﬁcantly higher methylation levels were
found in tumors. A median methylation level of 0.451 for
the tumor and 0.294 for the normal samples has been determ-
ined (Figure 6A). Wilcoxon analysis identiﬁed a signiﬁcant
class separation with a P-value of 0.00143. A detailed analysis
of cancer samples compared with their corresponding normal
adjacent tissue demonstrated an increased methylation level of
the tumors in all cases. Pyrosequencing conﬁrmed the PNA
hybridization data.
CONCLUSIONS
A novel DNA methylation analysis method for the validation
of candidate markers in tissue samples has been introduced.
Reliable relative quantitation of methylation levels in hetero-
geneous tissues is achieved by PNA hybridization and
subsequent MALDI-TOF-MS analysis. This method enables
Table 2. Characteristic values of evaluated assays
Assay PCR
length(bp)
Number of
CpGs in probe
C-content(%)
in probe
Measurement
range
a
APC-2 123 1 45 0.02
APC-1 123 1 36 0.16
EYA4-1 227 1 18 0.17
GSK3b-3 66 1 55 0.18
hMLH1-2 180 2 45 0.19
hMLH1-3 77 1 36 0.26
hMLH1-1 180 2 36 0.4
GSK3b-1 66 1 36 0.54
APC-3 123 2 27 0.57
GSK3b-2 66 2 36 0.68
MDR1-1 53 1 27 0.71
EYA4-2 69 2 29 0.88
aDifference of measured methylation levels for methylated and unmethylated
DNA ¼ (CG/(CG+CA)meth   (CG/(CG+CA)unmeth) ¼ Maximum range of
measurable values. High values allow a higher resolution of methylation
measurement.
Figure 3. ComparisonofPNAprobescoveringoneortwo CpGpositions.(AandB) AssayswithPNAprobescontainingtwoCG orCA-sequenceseach.(Cand D)
Assays with PNA probes covering one CpG. Analyzed genes: (A) EYA4-2, (B) APC-3, (C) hMLH1-3 and (D) GSK3b-1.
Figure 4. Comparison of singleplex and multiplex analysis. GSK3b promoter
methylation analysis on DNA methylation mixtures using three PNA probe
pairs both in singleplex and multiplex hybridizations. Correlation coefficients:
GSK3b-1 (0.935); GSK3b-2 (0.921), GSK3b-3 (0.896).
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markers in a single measurement and can therefore be per-
formed in high throughput. In contrast to primer extension and
sequencing based methods, our approach uses hybridization
for the sequence identiﬁcation. This enables the investigation
of adjacent methylated CpGs (co-methylated). Due to their
more stable nature, co-methylated sequences have a higher
biological impact than single methylated CpGs, which can
be the result of a non-speciﬁc random process (47). PNA
hybridization therefore represents a signiﬁcant advantage
over the direct PCR product sequencing or primer extension
based methods. These techniques do not have the ability to
distinguish speciﬁc methylation patterns. In contrast they
measure an average methylation level for each position. Iden-
tiﬁed co-methylated CpGs are suitable for the subsequent
development of methylation detection assays, such as
MethyLight, QAMA (quantitative analysis of methylated
alleles), HM (HeavyMethyl) or MSP analysis (15,16,48,49).
The method can be used to perform multiplex analysis
which allows the usage of small amounts of sample material
and enables the parallel analysis of several methylation posi-
tions. The method is relatively inexpensive when large num-
bers of samples have to be analyzed.
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